Yasuda J

ORCID: 0000-0002-3887-6871 · 4 papers in corpus · active 2003-2025

Study types

  • other 1

Condition tags

  • endometriosis 1
2025
Sequential Plasma Metabolome and Proteome Analyses to Develop a Novel Monitoring Strategy for Patients with Epithelial Ovarian Cancer: A Pilot Study.
International journal of molecular sciences ·doi:10.3390/ijms26125435

Epithelial ovarian cancer (EOC) is diagnosed at an advanced stage in over half of the patients and its prognosis remains unfavorable. CA125, one of the most frequent positive tumor markers in patients with EOC, has certain limitations. Ther…

2021
Liquid biopsy with droplet digital PCR targeted to specific mutations in plasma cell-free tumor DNA can detect ovarian cancer recurrence earlier than CA125.
Gynecologic oncology reports ·doi:10.1016/j.gore.2021.100847

ObjectiveOvarian cancer (OC) is an intractable gynecological tumor, and frequent recurrence is experienced within a few years even after the complete eradication of tumor tissues by radical resection and neo-adjuvant chemotherapies. The con…

other 2018
Identification of somatic genetic alterations in ovarian clear cell carcinoma with next generation sequencing
Genes, chromosomes & cancer ·doi:10.1002/gcc.22507

Ovarian clear cell carcinoma (OCCC) is the most refractory subtype of ovarian cancer and more prevalent in Japanese than Caucasians (25% and 5% of all ovarian cancer, respectively). The aim of this study is to discover the genomic alteratio…

2003
Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma.
The American Journal of Pathology ·doi:10.1016/s0002-9440(10)63605-x

Of all of the epithelial ovarian cancers, clear cell carcinoma (CCC) of the ovary has the worst prognosis. We applied the oligonucleotide array technique to identify genes generally involved in CCC. Of the approximately 12,600 genes that we…